Serial #79351364
LIVE

Serial Number

79351364

Owner

PRESTIGE BIOPHARMA KOREA CO., LTD

Attorney

Govinda M. Davis

Filing Date

Aug 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79351364 Trademark

Serial Number: 79351364 • Registration: 7251282

Serial #79351364 is a trademark filed by PRESTIGE BIOPHARMA KOREA CO., LTD on August 8, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PRESTIGE BIOPHARMA KOREA CO., LTD

11F, 44, Myeongjigukje 7-ro, Gangseo-gu

Entity Type: 16

Trademark Details

Filing Date

August 8, 2022

Registration Date

December 26, 2023

Published for Opposition

October 10, 2023

Goods & Services

Laboratory equipment, namely, incubators for cell culture; bioreactor for cell culturing; disposable plastic bioreactors for cell culture; cell culture apparatus for laboratory use, namely, cell culture dishes, scaffolds, well plates, flasks, microscopes; bioreactors for laboratory use; bioreactors for research use; fast liquid chromatography columns for laboratory use; fast liquid chromatography apparatus for laboratory use; laboratory chemical reactors; chemistry apparatus and instruments, namely, sensors analyzing diseased cells and monitoring reagents; apparatus and instruments for physics, namely, sensors for measuring cell activity, movement, growth and stress; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

Business administration; retail store services featuring biopharmaceuticals; business intermediary services relating to the purchase and sale of biopharmaceuticals, namely, providing sales leads for the biopharmaceutical industry; sales agency services for biopharmaceuticals, namely, telephone and online order-taking services for others; sales arranging of biopharmaceuticals, namely, telephone and online order-taking services for others; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; business intermediary services relating to the purchase and sale of pharmaceuticals namely, providing sales leads for the pharmaceutical industry; sales agency services for pharmaceuticals, namely, telephone and online order-taking services for others; sales arranging of pharmaceuticals, namely, telephone and online order-taking services for others

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials, namely, processing of biopharmaceutical materials; processing of medical products, namely, chemical processing of pharmaceuticals; custom manufacture of pharmaceuticals; processing of chemicals; chemical processing of medicinal materials

Biotechnology research; advisory services relating to biotechnology, namely, technological research relating to pharmaceutical manufacturing process technology; research and development of technology for biotechnology; consulting in the field of biotechnology, namely, providing consultation, advice, and information in the field of engineering research; laboratory research in the field of biology; research and development of biopharmaceuticals; consulting services relating to biopharmaceuticals product development; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development for the treatment of viral and infectious diseases, for the treatment of cancer; development of pharmaceutical preparations and medicines; clinical research in the field of medicine; development of biologics; design of biologics; research of biologics

Chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; biological preparations for use in cell cultures in the field of biotechnology, other than medical use; biochemicals for in vitro and in vivo scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; catalysts for use in biochemical processes; biochemical catalysts; catalysts for chemical and biochemical processes; chemical additives for use in the manufacture of cosmetics; buffer solutions for use in analytical chemistry; reagents for chemical analyses; reagents for use in scientific apparatus for chemical or biological analysis; cultures of microorganisms, other than for medical and veterinary use for scientific or laboratory purposes and for character change for scientific or laboratory purposes; biological preparations, other than for medical or veterinary purposes, for character change for scientific or laboratory purposes; biological preparation for use in cell cultures other than for medical or veterinary use

Biological preparations for medical purposes for the treatment of cancer and prevention of viruses; biopharmaceuticals preparations for the treatment of cancer and prevention of viruses; biopharmaceutical preparations for treating infectious disease; [ pharmaceutical preparations for the treatment of cancer and prevention of viruses; ] chemical preparations for pharmaceutical purposes for the treatment of cancer and prevention of viruses; pills for pharmaceutical purposes for the treatment of cancer and prevention of viruses; chemico-pharmaceutical preparations for the treatment of cancer and prevention of viruses; biotechnological preparations for medical use. namely, pharmaceutical preparations for the treatment of cancer and prevention of viruses; medicines for human purposes for the treatment of cancer and prevention of viruses; pharmaceutical preparations for the treatment of cancer and prevention of viruses; viral vaccines; human vaccine preparations; veterinary vaccines; human immune globulin sold as a pharmaceutical preparation for the treatment of cancer and prevention of viruses; biosimilar pharmaceutical preparations for the treatment of cancer and prevention of viruses; pharmaceutical preparations for immunity adjustment; biopharmaceuticals for the treatment of cancer

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Dec 2, 2025 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 14, 2025 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 13, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 13, 2025 APRE
LIMITATION OF GOODS RECEIVED FROM IB
Dec 28, 2024 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 15, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 26, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 26, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 26, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 26, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 26, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 10, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 10, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 20, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 20, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 30, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 25, 2023 CNRT
ASSIGNED TO EXAMINER
May 25, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 4, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 29, 2022 REPR